Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00320_DB00952_nanopub.RAaNl7CXVMRQOuyPCE-dVDRP7VS6i-fE7B3voNtvQN944#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00320_DB00952 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00320_DB00952 label "DDI between Dihydroergotamine and Naratriptan - Naratriptan, a serotonin 5-HT1D receptor agonists, may increase the vasoconstricting effect of dihydroergotamine. Concomitant use of these two agents within 24 hours is contraindicated. [drugbank_resource:DB00320_DB00952]" assertion.
- drugbank_resource:DB00320_DB00952 identifier "drugbank_resource:DB00320_DB00952" assertion.
- drugbank_resource:DB00320_DB00952 title "DDI between Dihydroergotamine and Naratriptan - Naratriptan, a serotonin 5-HT1D receptor agonists, may increase the vasoconstricting effect of dihydroergotamine. Concomitant use of these two agents within 24 hours is contraindicated." assertion.
- drugbank:DB00320 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00320_DB00952 assertion.
- drugbank:DB00952 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00320_DB00952 assertion.